Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT06096779

A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis

Led by Genentech, Inc. · Updated on 2026-05-04

30

Participants Needed

61

Research Sites

180 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to assess the safety of atezolizumab and bevacizumab, or atezolizumab alone, as first-line treatment in participants with unresectable, locally advanced or metastatic hepatocellular carcinoma (HCC) with Child-pugh B7 or B8 cirrhosis.

CONDITIONS

Official Title

A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Locally advanced or metastatic and/or unresectable hepatocellular carcinoma confirmed by biopsy or clinical criteria
  • Disease not suitable for curative surgery or local therapies
  • No prior systemic treatment for advanced or unresectable hepatocellular carcinoma
  • At least one measurable untreated tumor lesion
  • ECOG performance status of 0 to 2 within 7 days before treatment
  • Child-Pugh B7 or B8 cirrhosis at screening and within 7 days before treatment
  • Adequate blood counts and organ function
  • Life expectancy of at least 12 weeks
  • Women of childbearing potential must agree to avoid pregnancy and egg donation
  • Absolute neutrophil count ≥1.0 x 10^9/L without growth factor support
  • Platelet count ≥50,000/µL without transfusion
  • Hemoglobin ≥80 g/L (8 g/dL)
  • AST and ALT ≤5 times upper limit of normal
  • Serum bilirubin ≤3 times upper limit of normal
  • Creatinine clearance ≥50 mL/min by Cockcroft-Gault formula
  • Serum albumin ≥20 g/L (2.0 g/dL) without transfusion in past 3 months
  • INR ≤2.3
Not Eligible

You will not qualify if you...

  • Pregnancy or breastfeeding
  • Prior treatment with CD137 agonists or immune checkpoint inhibitors
  • Investigational therapy within 28 days before study treatment
  • Locoregional liver therapy within 28 days before study treatment or unresolved side effects
  • Treatment with systemic immunostimulatory or immunosuppressive medications
  • Live vaccine within 4 weeks before study treatment
  • Uncontrolled high blood pressure
  • Active or past autoimmune disease or immune deficiency
  • History of pulmonary fibrosis, organizing pneumonia, drug-induced or idiopathic pneumonitis, or active pneumonitis on chest CT
  • Concurrent progressing malignancy requiring treatment or recent malignancy history that excludes participation
  • Known fibrolamellar or sarcomatoid hepatocellular carcinoma, or mixed cholangiocarcinoma and hepatocellular carcinoma
  • Symptomatic or untreated central nervous system metastases
  • Prior allogeneic stem cell or organ transplant
  • Currently listed for liver transplantation
  • Co-infection with hepatitis B and C viruses
  • Untreated or high-risk esophageal or gastric varices
  • Bleeding events from varices or grade ≥3 hemorrhage within 6 months before treatment
  • Active hepatic encephalopathy symptoms or instability within 3 months
  • History or planned transjugular intrahepatic portosystemic shunt (TIPS) placement (excluded in Cohort A)
  • Multiple paracenteses restrictions as specified
  • Recent spontaneous bacterial peritonitis within 12 months

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 61 locations

1

University of Arizona Cancer Center

Tucson, Arizona, United States, 85724

Actively Recruiting

2

UC San Diego Moores Cancer Center

La Jolla, California, United States, 92093

Actively Recruiting

3

University of Southern California-Keck School of Medicine -1975 Zonal Ave

Los Angeles, California, United States, 90089-5601

Actively Recruiting

4

University of Southern California

Newport Beach, California, United States, 92663

Actively Recruiting

5

University of California Irvine Medical Center

Orange, California, United States, 92868

Completed

6

California Liver Research Institute

Pasadena, California, United States, 91105-2561

Actively Recruiting

7

University of California Davis Medical Center

Sacramento, California, United States, 95817

Completed

8

Stanford Health Care

Stanford, California, United States, 94305

Actively Recruiting

9

Harbor UCLA Medical Center

Torrance, California, United States, 90502-2006

Actively Recruiting

10

Cedars Sinai Comprehensive Transplant Center

West Hollywood, California, United States, 90048-2422

Actively Recruiting

11

Rocky Mountain Cancer Centers (Williams) - USOR

Denver, Colorado, United States, 80218-1237

Actively Recruiting

12

Hartford Healthcare Cancer Institute at Hartford Hospital

Hartford, Connecticut, United States, 06106

Actively Recruiting

13

Washington DC VA Medical Center

Washington D.C., District of Columbia, United States, 20422-0001

Actively Recruiting

14

Orlando Health Inc.

Orlando, Florida, United States, 32806

Actively Recruiting

15

Northwestern University

Chicago, Illinois, United States, 60611-2908

Actively Recruiting

16

University of Illinois Health Outpatient Care Center

Chicago, Illinois, United States, 60612-4795

Actively Recruiting

17

The Duchossois Center for Advanced Medicine

Chicago, Illinois, United States, 60637-1426

Actively Recruiting

18

University of Kentucky - Markey Cancer Center

Lexington, Kentucky, United States, 40536-7001

Actively Recruiting

19

LSU Health Baton Rouge

Baton Rouge, Louisiana, United States, 70805

Actively Recruiting

20

Our Lady of the Lake Cancer Institute

Baton Rouge, Louisiana, United States, 70808-4300

Actively Recruiting

21

Tufts Medical Center

Boston, Massachusetts, United States, 02111

Actively Recruiting

22

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States, 02215

Actively Recruiting

23

Veterans Affairs Ann Arbor Healthcare System

Ann Arbor, Michigan, United States, 48105

Actively Recruiting

24

Barbara Ann Karmanos Cancer Institute

Detroit, Michigan, United States, 48201

Actively Recruiting

25

Henry Ford Health System

Detroit, Michigan, United States, 48202

Actively Recruiting

26

Saint Luke?s Hospital of Kansas City

Kansas City, Missouri, United States, 64111

Actively Recruiting

27

MorristownMedicalCenter

Morristown, New Jersey, United States, 07962

Actively Recruiting

28

Rutgers Cancer Institute of New Jersey

New Brunswick, New Jersey, United States, 08901

Actively Recruiting

29

Rutgers Cancer Institute of New Jersey at University Hospital

Newark, New Jersey, United States, 07103

Actively Recruiting

30

Long Island Heart Associates

Mineola, New York, United States, 11501-4298

Actively Recruiting

31

R.J. Zuckerberg Cancer Hospital/Northwell Health - BRANY - PPDS

New Hyde Park, New York, United States, 11042-1118

Withdrawn

32

NYU Langone Medical Center

New York, New York, United States, 10016-9451

Actively Recruiting

33

Icahn School of Medicine at Mount Sinai

New York, New York, United States, 10029

Actively Recruiting

34

Montefiore Medical Center

The Bronx, New York, United States, 10467

Actively Recruiting

35

James J Peters Veterans Administration Medical Center - NAVREF

The Bronx, New York, United States, 10468-3904

Actively Recruiting

36

Levine Cancer Institute

Charlotte, North Carolina, United States, 28204

Actively Recruiting

37

University Hospitals Cleveland Medical Center

Cleveland, Ohio, United States, 44106

Withdrawn

38

Dayton VA Medical Center - NAVREF - PPDS

Dayton, Ohio, United States, 45428-9000

Actively Recruiting

39

The University of Oklahoma Health Sciences Center

Oklahoma City, Oklahoma, United States, 73104-5020

Actively Recruiting

40

Kaiser Permanente Westside Medical Center

Hillsboro, Oregon, United States, 97124-5806

Actively Recruiting

41

OHSU Knight Cancer Institute Hematology Oncology

Portland, Oregon, United States, 97239-3011

Actively Recruiting

42

Jefferson Health Honickman Center

Philadelphia, Pennsylvania, United States, 19107

Actively Recruiting

43

Veterans Affairs Pittsburgh Healthcare System - NAVREF - PPDS

Pittsburgh, Pennsylvania, United States, 15240

Completed

44

The West Clinic (East Campus)

Germantown, Tennessee, United States, 38138-1762

Active, Not Recruiting

45

Nashville General Hospital at Meharry

Nashville, Tennessee, United States, 37208-2918

Actively Recruiting

46

Liver Institute at Methodist Dallas

Dallas, Texas, United States, 75203-1260

Actively Recruiting

47

Moody Outpatient Center ? Parkland Health

Dallas, Texas, United States, 75235

Actively Recruiting

48

Texas Oncology (Worth) - USOR

Dallas, Texas, United States, 75246-2008

Actively Recruiting

49

University of Texas Southwestern Medical Center

Dallas, Texas, United States, 75390-0001

Actively Recruiting

50

Texas Oncology - Denison Cancer Center

Denison, Texas, United States, 75020-0084

Actively Recruiting

51

Kelsey Research Foundation

Houston, Texas, United States, 77025-1669

Actively Recruiting

52

Michael E Debakey VA Medical Center - NAVREF - PPDS

Houston, Texas, United States, 77030-4211

Actively Recruiting

53

Houston Methodist Hospital

Houston, Texas, United States, 77030

Actively Recruiting

54

Intermountain Healthcare

Murray, Utah, United States, 84107-5741

Actively Recruiting

55

Intermountain Cancer Center

St. George, Utah, United States, 84790

Actively Recruiting

56

Inova Schar Cancer Institute

Falls Church, Virginia, United States, 22042

Completed

57

Maryview Hospital, Inc.

Newport News, Virginia, United States, 23602

Withdrawn

58

Bon Secours St. Mary's Hospital

Richmond, Virginia, United States, 23226-1925

Actively Recruiting

59

VCU Medical Center North Hospital

Richmond, Virginia, United States, 23298-5028

Actively Recruiting

60

Virginia Mason Medical Center

Seattle, Washington, United States, 98101

Actively Recruiting

61

Pan American Center for Oncology Trials, LLC

Rio Piedras, Puerto Rico, 00935

Actively Recruiting

Loading map...

Research Team

R

Reference Study ID Number: ML44719 https://forpatients.roche.com/

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here